By Will Feuer Shares of Verrica Pharmaceuticals climbed after its development and commercialization partner, Torii Pharmaceutical, reported positive top-line.
By Chris Wack Verrica Pharmaceuticals shares fell 35% to $4.86 after the company entered into a non-binding term sheet for a term loan facility of up to $125.
By Denny Jacob Verrica Pharmaceuticals on Friday said the Food and Drug Administration approved Ycanth topical solution to treat molluscum contagiosum in.
By Denny Jacob Shares of Verrica Pharmaceuticals were down on Friday after the company said the Food and Drug Administration approved Ycanth topical solution.